Diego Cortese

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

The non-canonical BAF chromatin remodeling complex is a novel target of spliceosome dysregulation in SF3B1-mutated chronic lymphocytic leukemia.

The non-canonical BAF chromatin remodeling complex is a novel target of spliceosome dysregulation in SF3B1-mutated chronic lymphocytic leukemia.

Journal: Leukemia
Published: March 28, 2024

BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib.

BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib.

Journal: Blood advances
Published: August 24, 2022

Comparative analysis of targeted next-generation sequencing panels for the detection of gene mutations in chronic lymphocytic leukemia: an ERIC multi-center study.

Comparative analysis of targeted next-generation sequencing panels for the detection of gene mutations in chronic lymphocytic leukemia: an ERIC multi-center study.

Journal: Haematologica
Published: February 11, 2020

Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia.

Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia.

Journal: Haematologica
Published: April 12, 2018

UGT2B17 expression: a novel prognostic marker within IGHV-mutated chronic lymphocytic leukemia?

UGT2B17 expression: a novel prognostic marker within IGHV-mutated chronic lymphocytic leukemia?

Journal: Haematologica
Published: November 22, 2015

Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations.

Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations.

Journal: Blood
Published: October 13, 2015

Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting.

Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting.

Journal: Haematologica
Published: December 07, 2014

Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia.

Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia.

Journal: The Journal of experimental medicine
Published: October 23, 2014

Recurrent mutations refine prognosis in chronic lymphocytic leukemia.

Recurrent mutations refine prognosis in chronic lymphocytic leukemia.

Journal: Leukemia
Published: April 09, 2014

On the way towards a 'CLL prognostic index': focus on TP53, BIRC3, SF3B1, NOTCH1 and MYD88 in a population-based cohort.

On the way towards a 'CLL prognostic index': focus on TP53, BIRC3, SF3B1, NOTCH1 and MYD88 in a population-based cohort.

Journal: Leukemia
Published: November 13, 2013

Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2.

Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2.

Journal: Leukemia
Published: March 17, 2013

Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?

Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?

Journal: Leukemia & lymphoma
Published: March 14, 2013
Showing 1-12 of 12

Last Updated: 09/26/2026